Official recall notice

FDA DrugClass IINotable

Dextroamphetamine Saccharate Amphetamine Recall (Jul 2026)

Product: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.

Recall date
2026-07-08
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

Affected products

Lot#: 25285401A, Exp. Date: 04/2027

Verify with the official notice →
Share:

Related Recalls

2026-06-10 · FDA_DRUG
FDA Recall: Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett C
Lannett Company Inc.
2026-05-27 · FDA_DRUG
FDA Recall: Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Phil
Lannett Company Inc.